Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.44 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.44 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ANPEP | P15144 | 1/20 | 0.39 |
| ▸ | LAP3 | P28838 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL14645200 | 0.92 | LMNA (0.44) | LMNAMTNR1AMTNR1BADRB2ADRB1 | |
| Propanol SCHEMBL6407074 | 0.92 | LMNA (0.47) | LMNAMTNR1AMTNR1BADRB2ADRB1 | |
| Ethylene Glycol SCHEMBL9388302 | 0.91 | LMNA (0.50) | LMNAMTNR1AMTNR1BADRB2ADRB1 | |
| SCHEMBL167127 | 0.91 | LMNA (0.52) | LMNAMTNR1AMTNR1BADRB2ADRB1 | |
| SCHEMBL15709 | 0.91 | LMNA (0.52) | LMNAMTNR1AMTNR1BADRB2ADRB1 | |
| Benzene SCHEMBL28097669 | 0.91 | LMNA (0.52) | LMNAMTNR1AMTNR1BADRB2ADRB1 | |
| Propylene Glycol SCHEMBL28268584 | 0.89 | LMNA (0.53) | LMNAMTNR1AMTNR1BADRB2ADRB1 | |
| Methyl Alcohol SCHEMBL7078021 | 0.89 | LMNA (0.50) | LMNAMTNR1AMTNR1BADRB2ADRB1 | |
| Hydrochloric Acid SCHEMBL12613519 | 0.89 | LMNA (0.50) | LMNAMTNR1AMTNR1BADRB2ADRB1 | |
| SCHEMBL21803703 | 0.89 | LMNA (0.50) | LMNAMTNR1AMTNR1BADRB2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3798275-B1 | CERAMIC INK AND USE THEREOF FOR DECORATING CERAMIC OBJECTS | SMALTICERAM UNICER S P A (IT) | 2022-07-13 | — | — | EP | claimed |
| EP-3798275-A1 | CERAMIC INK AND USE THEREOF FOR DECORATING CERAMIC OBJECTS | SMALTICERAM UNICER S.P.A. (IT) | 2021-03-31 | — | — | EP | claimed |
| EP-2505060-B1 | New disinfectant mixture of alcool and glycerol ether for the control of mycobacteria | AIR LIQUIDE SANTE INT (FR) | 2016-09-14 | — | — | EP | claimed |
| EP-2790652-B1 | ENVIRONMENTALLY FRIENDLY, LOW WHITENING COMPOSITIONS | UNILEVER PLC (GB) | 2016-07-20 | — | — | EP | claimed |
| EP-1784074-B1 | ENHANCED ACTIVITY ALCOHOL-BASED ANTIMICROBIAL COMPOSITIONS | AMERICAN STERILIZER CO (US) | 2014-02-26 | — | — | EP | claimed |
| EP-1886686-B1 | Pharmaceutical composition containing mometasone furoate | ALMIRALL HERMAL GMBH (DE) | 2013-04-10 | — | — | EP | claimed |
| EP-1837402-B1 | Reagent for analyzing urine and method for analyzing urine | SYSMEX CORP (JP) | 2009-05-13 | — | — | EP | claimed |
| EP-1886686-A1 | Pharmaceutical composition containing mometasone furoate | Hermal Kurt Hermann GmbH & Co. OHG (DE) | 2008-02-13 | — | — | EP | claimed |
| EP-1720578-A2 | BACTERIOSTATIC ESTERS FOR TOPICAL USE | Vama Farmacosmetica S.R.L. (IT) | 2006-11-15 | — | — | EP | claimed |
| EP-1326644-B1 | ABSORPTION ENHANCERS | AXCESS LTD (GB) | 2006-07-05 | — | — | EP | claimed |
| WO-2005079852-A2 | BACTERIOSTATIC ESTERS FOR TOPICAL USE | VAMA FARMCOSMETICA S.R.L. (IT) | 2005-09-01 | — | — | WO | claimed |
| US-20050182124-A1 | Ester bacteriostat for stabilizing cosmetics | VAMA FARMACOSMETICA S.R.L. | 2005-08-18 | — | — | US | claimed |
| EP-0892785-B1 | ANTIMICROBIAL SOLUTION OF FORMALDEHYDE SUBSTITUTED HYDANTOIN AND PROCESS FOR PREPARATION | MCINTYRE GROUP LTD (US) | 2001-07-25 | — | — | EP | claimed |
| EP-0731634-B1 | ANATOMICAL AND BIOLOGICAL PRESERVATIVE AND IMPROVED EMBALMING COMPOSITION AND METHOD | EFH INC (US) | 1998-05-27 | — | — | EP | claimed |
| EP-3798275-B1 | CERAMIC INK AND USE THEREOF FOR DECORATING CERAMIC OBJECTS | SMALTICERAM UNICER S P A (IT) | 2022-07-13 | — | — | EP | disclosed |
| WO-2022135993-A2 | PHARMACEUTICAL COMPOSITION COMPRISING LIPID-BASED CARRIERS ENCAPSULATING RNA FOR MULTIDOSE ADMINISTRATION | CUREVAC AG (DE) | 2022-06-30 | — | — | WO | disclosed |
| CN-114366695-A | Moisturizing composition and preparation method thereof | 程瑶 | 2022-04-19 | — | — | CN | disclosed |
| WO-2001041573-A1 | THERAPEUTIC ANTIMICROBIAL COMPOSITIONS | ETHICON, INC. (US) | 2001-06-14 | — | — | WO | disclosed |
| US-5897857-A | SULFHYDRYL COMPOUND SELECTED FROM CYSTEINE, HOMOCYCTEINE, GLUTATHIONE, THIOGLYCEROL, THIOMALIC ACID, 2-MERCAPTOETHANOL, MERCAPTOPROPIONIC ACIDS, DITHIOTHREITOL, THIOSALICYLIC ACID, N-ACETYL-L-CYSTEIN AND SALTS; FACIAL HAIR REMOVER | THE PROCTER & GAMBLE COMPANY (US) | 1999-04-27 | — | — | US | disclosed |
| US-5405606-A | Mixture of glutaraldehyde, phenoxyethanol and alcohol | EFH, INC. (US) | 1995-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050182124-A1 | Ester bacteriostat for stabilizing cosmetics | CUTA, PGA5, ACP3 | LMNA 2837/4885MTNR1A 1712/4885MTNR1B 2879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.